A methylation-related signature for predicting prognosis and sensitivity to first-line therapies in gastric cancer.
Cao C, Luo Z, Zhang H, Yao S, Lu H, Zheng K, Wang Y, Zou M, Qin W, Xiong H, Yuan X, Wang Y, Pinheiro RN, Peixoto RD, Zou Y, Xiong H.
Cao C, et al. Among authors: zou y, zou m.
J Gastrointest Oncol. 2023 Dec 31;14(6):2354-2372. doi: 10.21037/jgo-23-770. Epub 2023 Dec 27.
J Gastrointest Oncol. 2023.
PMID: 38196539
Free PMC article.